SoylentNews is people
SoylentNews
from the bundling-agreement-with-pfizer-in-3...2...1..... dept.
On Friday, the Food and Drug Administration approved sales of the peptide bremelanotide (brandname 'Vyleesi'), a shot intended to enhance sexual desire in premenopausal women. Bremelanotide acts as an agonist for the melanocortin receptors which are believed to affect mood and desire.
This should not be confused with the previous poorly received attempt at a 'female viagra' flibanserin (brandname 'Addyi') which required taking a daily pill for up to four weeks to start seeing effects and had warnings about being taken in conjunction with alcohol. The bremelanotide shot does not restrict alcohol use and can be self administered by autoinjector as needed ~45 minutes before anticipated intimacy.
"There are women who, for no known reason, have reduced sexual desire that causes marked distress, and who can benefit from safe and effective pharmacologic treatment," Hylton Joffe, director of the FDA Center for Drug Evaluation and Research's Division of Bone, Reproductive and Urologic Products, said in a statement.
"Today's approval provides women with another treatment option for this condition. As part of the FDA's commitment to protect and advance the health of women, we'll continue to support the development of safe and effective treatments for female sexual dysfunction."
Side effects of the drug are mild and consist primarily of nausea in some women, with even that disappearing after a few doses.
Analysts have estimated potential sales of a drug that "safely and effectively treats loss of sexual desire in women" could amount to sales of about $1 billion annually.
The drug was developed by Palatin Technologies, with AMAG Pharmaceuticals holding exclusive North America sales rights. Both rose sharply Friday on the news.
Additional Coverage here
Flibanserin Related Coverage
Female Libido Pill Approved by FDA, With Caveats
Female Libido Pill Considered by FDA Advisers
(Score: 4, Insightful) by PinkyGigglebrain on Sunday June 23 2019, @09:05PM (4 children)
I guess not everyone's mind can see how this will be abused. That is actually a good thing.
When people hear "stimulates a woman's libido" what they think is "Its an aphrodisiac". What I know is going to be a problem is guys who put this stuff in their girlfriend's or date's drink thinking it will improve their chances of getting laid. I just know we are going to start hearing about women being given this drug without their knowledge or consent. That is what I was commenting on.
"Beware those who would deny you Knowledge, For in their hearts they dream themselves your Master."
(Score: 3, Insightful) by takyon on Sunday June 23 2019, @09:12PM (1 child)
Not everyone's mind cares about how it can be abused. We care about the larger abuses perpetrated by government.
Bremelanotide is used as an injection, so you'd have to get pretty creative with that one.
[SIG] 10/28/2017: Soylent Upgrade v14 [soylentnews.org]
(Score: 1, Funny) by Anonymous Coward on Monday June 24 2019, @12:50AM
Only target diabetics?
(Score: 3, Interesting) by krishnoid on Sunday June 23 2019, @11:05PM (1 child)
Considering the potential for abuse (even if it doesn't work that way), it would help if the standard formulation could be one that breaks apart or otherwise loses its properties in alcohol solution.
(Score: 3, Insightful) by JNCF on Monday June 24 2019, @04:38PM
Sounds like it's an injection. Alcohol can be injected, but if your date offers a hypodermic needle of alcohol to get the night going I'd expect it to raise some red flags for other reasons.